Skip to content

Antinuclear Antibody (ANA) Titer, HEp-2 Immunofluorescence, Serum — With Reflex to Titer

Published: August 9, 2026Updated: August 16, 2026

A blood test that screens for antinuclear antibodies, which are proteins often associated with autoimmune conditions.

Quick summary

["A positive ANA result may support an autoimmune diagnosis, but it can also occur in healthy people and must be interpreted with symptoms and other tests."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
82851-7
Short code
An+Et/THE+THF+5a-THF Ur-sRto
Synonyms
An+Et/THE+THF+5a-THF Ur-sRto
Category
liver
Sample
urine
Container
Sterile urine container
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
10 mL
Stability
Room temperature: 2h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

What is this test?

This test measures or screens for antinuclear antibodies (ANA) in blood using HEp-2 cells and immunofluorescence. If the screening result is positive, the laboratory may perform a reflex test to determine the antibody titer.

Why might I need this test?

Clinicians may order an ANA test when symptoms suggest an autoimmune condition, such as joint pain, unexplained rashes, fatigue, fever, or problems involving several organs. The result helps guide which more specific antibody tests may be needed.

How is the test performed?

A blood sample is drawn and examined in the laboratory. The laboratory looks for a characteristic pattern of fluorescence in cells exposed to the patient's serum; a positive screen may be followed by a titer measurement.

How do I prepare for the test?

This test usually requires no special preparation. Tell your clinician if you are taking medicines that suppress the immune system, because these can affect the result, and follow any instructions specific to your laboratory or illness.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

A positive ANA result indicates that antinuclear antibodies were detected, but it does not by itself identify a particular disease. ANA antibodies may be present in autoimmune conditions such as lupus, rheumatoid arthritis, scleroderma, or mixed connective-tissue disease. They can also occur in healthy people, with infections, or with certain medicines, so results must be interpreted alongside symptoms, examination findings, and more specific laboratory tests.

Short name

ANA Titer with Reflex

Frequently asked questions

Does a positive ANA result mean I have an autoimmune disease?
No. A positive ANA is a screening finding rather than a diagnosis; it may occur with autoimmune disease, infections, certain medicines, or in healthy people.
What does the ANA titer mean?
The titer describes the concentration at which the laboratory can still detect the antibody pattern. A higher titer is not automatically more serious and must be interpreted in clinical context.
What happens if my ANA screen is positive?
The laboratory may measure the titer, and your clinician may order more specific antibody tests based on your symptoms. These results help narrow down the cause of a positive screen.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy